RESIL Receives Expanded Certification for Biostimulant Claims Across the EU
18 June 2025, London: BioLiNE Corporation’s flagship biostimulant, RESIL, has achieved a significant regulatory milestone in the European Union. Marketed in Europe
Read More
18 June 2025, London: BioLiNE Corporation’s flagship biostimulant, RESIL, has achieved a significant regulatory milestone in the European Union. Marketed in Europe
Read MoreCheck Offers Available
